This inventor holds 1 USPTO granted patent. Top assignees: Molecular Targeting Technologies. Inc., Temple University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2021
Title: Parkson L-g Chong: Innovator in Anti-thrombotic Agents
Introduction
Parkson L-g Chong is a notable inventor based in Cherry Hill, NJ (US). He has made significant contributions to the field of medicine, particularly in the development of anti-thrombotic agents. His work focuses on compositions and methods for treating platelet-related diseases, which are crucial for improving patient outcomes in various medical conditions.
Latest Patents
Chong holds one patent titled "Anti-thrombotic agents and methods of use thereof." This invention is related to innovative compositions and methods aimed at treating diseases associated with platelet function. The patent reflects his commitment to advancing medical science and improving therapeutic options for patients.
Career Highlights
Throughout his career, Parkson L-g Chong has worked with esteemed institutions such as Temple University and Molecular Targeting Technologies, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Chong has collaborated with notable individuals, including Lawrence E Goldfinger and Koon Y Pak. These partnerships have enriched his research and expanded the impact of his inventions in the medical community.
Conclusion
Parkson L-g Chong's innovative work in anti-thrombotic agents showcases his dedication to improving healthcare through scientific advancements. His contributions are vital for the treatment of platelet-related diseases, and his career reflects a commitment to excellence in research and collaboration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile